EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Diacerein attenuates cisplatin-induced cerebellar neurotoxicity in rats: modulation of PI3K/AKT signaling and inhibition of NLRP3-mediated pyroptosis

Ahmad Fallata

Annals of Clinical and Analytical Medicine · 2026-11-01 · 17 (11) · 1211-1216

DOI: 10.4328/acam.50231 ↗
AbstractBibliografische Angaben

Abstract

Aim This study investigated Diacerein’s capacity to protect the cerebellum from cisplatin-driven neurotoxicity characterized by oxidative stress, inflammation, and apoptosis and clarified the associated molecular pathways. Methods Forty adult male Wistar rats were assigned to four groups: control, Diacerein (100 mg/kg), cisplatin (10 mg/kg), and cisplatin plus Diacerein. After seven days of treatment, cerebellar tissues were assessed for oxidative, inflammatory, apoptotic, and pyroptotic alterations using biochemical assays, ELISA, and qRT-PCR. Results Cisplatin exposure caused profound cerebellar degeneration, evidenced by heightened lipid peroxidation, depletion of endogenous antioxidant defenses, and marked suppression of the PI3K/AKT survival pathway. These disturbances were accompanied by robust activation of the NF-κB/NLRP3 inflammasome axis, resulting in elevated pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) and increased pyroptotic mediators (caspase-1, IL-18, GSDMD). Apoptotic imbalance was also apparent, with upregulation of Bax and caspase-3 and reduced Bcl-2 expression. Histopathological examination corroborated these biochemical disruptions. Co-administration of Diacerein significantly mitigated cisplatin-induced cerebellar toxicity by restoring redox homeostasis, reactivating PI3K/AKT signaling, and suppressing NF-κB-driven inflammatory and pyroptotic cascades. Diacerein also normalized apoptotic markers and preserved cerebellar architecture. Conclusion Collectively, these findings indicate that Diacerein affords substantial neuroprotection against cisplatin-induced cerebellar degeneration through coordinated modulation of oxidative stress, inflammation, and programmed cell death pathways, highlighting its promise as an adjuvant strategy to reduce chemotherapy-associated neurotoxicity.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →